Target intelligence / Profile preview

Pseudogene similar to part of excision repair cross-complementing rodent repair deficiency, complementation group 3

Molecular classification
Pseudogene
01

Overview

This gene (ENSG00000226750) is annotated as a **pseudogene** that has sequence similarity to part of the ERCC3 gene ("excision repair cross-complementing rodent repair deficiency, complementation group 3"), also known as XPB. Unlike the functional ERCC3 gene, which encodes a DNA helicase essential for nucleotide excision repair and regulation of transcription, this pseudogene does not encode a functional protein and is not considered a therapeutic target[5][6]. Pseudogenes may arise from gene duplication or retrotransposition events but lack coding potential and are generally not involved in disease or drug interaction. There is no evidence of a functional role, disease mechanism, or utility as a therapeutic target for ENSG00000226750. **Summary:** ENSG00000226750 is a pseudogene, not a protein-coding gene or functional receptor/enzyme/target. Information on canonical ERCC3 is not directly applicable to this entry, and it should not be considered a drug target or biomarker[5][6].

Beyond the preview

Go deeper on Pseudogene similar to part of excision repair cross-complementing rodent repair deficiency, complementation group 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of excision repair cross-complementing rodent repair deficiency, complementation group 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call